From: HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer
Characteristics | B | SE | Wald | HR | 95% CI | P value | |
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
Univariate | |||||||
Age | 0.068 | 0.186 | 0.133 | 1.070 | 0.744 | 1.539 | 0.715 |
Tumor size | 0.093 | 0.185 | 0.253 | 1.098 | 0.764 | 1.577 | 0.615 |
M classification | 0.151 | 0.192 | 0.620 | 1.163 | 0.799 | 1.693 | 0.431 |
LN | 0.406 | 0.185 | 4.795 | 1.500 | 1.043 | 2.157 | 0.029* |
Grade | 0.223 | 0.110 | 4.110 | 1.250 | 1.007 | 1.552 | 0.043* |
Clinical stage | 0.560 | 0.197 | 8.068 | 1.751 | 1.190 | 2.576 | 0.005** |
HBXIP | 0.717 | 0.195 | 13.575 | 2.049 | 1.399 | 3.000 | 0.000** |
Multivariate | |||||||
Grade | 0.104 | 0.116 | 0.797 | 1.109 | 0.883 | 1.394 | 0.372 |
LN | 0.221 | 0.194 | 1.295 | 1.247 | 0.853 | 1.823 | 0.255 |
Clinical stage | 0.422 | 0.204 | 4.289 | 1.526 | 1.023 | 2.275 | 0.038* |
HBXIP | 0.632 | 0.199 | 10.058 | 1.880 | 1.273 | 2.778 | 0.002** |